Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress
Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of its drug candidate for a...








